Local therapy in endometrial cancer: Evidence based review

Current Opinion in Oncology

Volumn 19, Issue 5, 2007, Pages 512-515

  Deeks, Emma ^a  

^a ADIS INTERNATIONAL LIMITED   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN;

BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; ENDOMETRIUM CANCER; GASTROINTESTINAL TOXICITY; HEMATOLOGIC DISEASE; HIGH RISK POPULATION; HUMAN; PRIORITY JOURNAL; REVIEW; SKIN TOXICITY; SURVIVAL RATE; UROGENITAL TRACT DISEASE;

ENDOMETRIAL NEOPLASMS; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; RANDOMIZED CONTROLLED TRIALS;

EID: 34548425194     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cco.0000284643.94948.44     Document Type: Review

References (14)

1. Jemal A, Siegal R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin 2007; 57:43-66.
2. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55:74-108.
3. Shaeffer DT, Randall ME. Adjuvant radiotherapy in endometrial carcinoma. Oncologist 2005; 10:623-631.
4. Kong A, Johnson N, Cornes P, et al. Adjuvant radiotherapy for stage I endometrial cancer (review). Cochrane Database of Systematic Reviews 2: CD003916, 2007.
5. Keys HM, Roberts JA, Brunetto VL, et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 2004; 92:744-751.
6. Creutzberg CL, van Putten WLJ, Koper PCM, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomized trial. Lancet 2000; 355:1404-1411.
7. Creutzberg CL, van Putten WLJ, Koper PCM, et al. Survival after relapse in patients with endometrial cancer: results from a randomized trial. Gynecol Oncol 2003; 89:201-209.
8. Creutzberg CL, van Putten WLJ, Koper PCM, et al. The morbidity of treatment for patients with stage I endometrial cancer: results from a randomized trial. Int J Radiation Oncology Biol Phys 2001; 51:1246-1255.
9. Soderini A, Anchezar JP, Sardi JE. Role of adjuvant radiotherapy (RT) in intermediate risk (IB G2-3-IC) endometrial carcinoma (EC) after extended staging surgery (ESS). Preliminary reports of a randomized trial. Int J Gynecol Cancer 2003; 13 (Suppl 1):78. [Abstract no. PO147].
10. Maggi R, Lissoni A, Spina F, et al. Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomized trial. Br J Cancer 2006; 95:266-271.
11. Sagae S, Udagawa Y, Susumu N, et al. A randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate risk endometrial carcinoma: a Japan Gynecological Oncology Group study. EJC Supplements 2005; 3:265. [Abstract no. 920].
12. Lukka H,Chambers A, Fyles A, et al. Adjuvant radiotherapy inwomenwith stage I endometrial cancer: a systematic review. Gynecol Oncol 2006; 102:361-368.
13. Look K. Stage I-II endometrial adenocarcinoma evolution of therapeutic paradigms: the role of surgery and adjuvant radiation. Int J Gynecol Cancer 2002; 12:237-249.
14. Stolyarova I, Minaev A. Effect of hormonotherapy on the results of radiation treatment in patients with endometrial carcinoma. Journal of the Balkan Union of Oncology 2001; 6:271-274.